Monday, December 27, 2010

Methotrexaat Sandoz




Methotrexaat Sandoz may be available in the countries listed below.


Ingredient matches for Methotrexaat Sandoz



Methotrexate

Methotrexate sodium salt (a derivative of Methotrexate) is reported as an ingredient of Methotrexaat Sandoz in the following countries:


  • Netherlands

International Drug Name Search

Saturday, December 25, 2010

Reteplase




In the US, Reteplase (reteplase systemic) is a member of the drug class thrombolytics and is used to treat Heart Attack.

US matches:

  • Reteplase

  • Reteplase, recombinant Intravenous

  • Reteplase, Recombinant

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B01AD07

CAS registry number (Chemical Abstracts Service)

0133652-38-7

Chemical Formula

C1736-H2653-N499-O522-S22

Molecular Weight

39573

Therapeutic Category

Anticoagulant agent: Fibrinolytic enzyme

Chemical Name

173-L-Serine-174-L-tyrosine-175-L-glutamine-173-527-plasminogen activator (human tissue-type)

Foreign Names

  • Reteplasum (Latin)
  • Reteplase (German)
  • Reteplase (French)
  • Reteplasa (Spanish)

Generic Names

  • Reteplase (OS: BAN, USAN)
  • BM 06022 (IS: Boehringer Mannheim)
  • r-PA (IS)

Brand Names

  • Rapilysin
    Actavis, United Arab Emirates; Actavis, Austria; Actavis, Australia; Actavis, Belgium; Actavis, Bahrain; Actavis, Switzerland; Actavis, Germany; Actavis, Denmark; Actavis, Finland; Actavis, France; Actavis, United Kingdom; Actavis, Greece; Actavis, Croatia (Hrvatska); Actavis, Ireland; Actavis, Italy; Actavis, Kuwait; Actavis, Luxembourg; Actavis, Netherlands; Actavis, Oman; Actavis, Portugal; Actavis, Qatar; Actavis, Romania; Actavis, Saudi Arabia; Actavis, Sweden; Actavis, Slovakia; Actavis, Yemen; Actavis Group, Spain; Actavis Group, Iceland; Healthcare Logistics, New Zealand; Roche, Norway


  • Retavase
    Biovail, Canada; Centocor, United States

International Drug Name Search

Glossary

BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, December 21, 2010

Apo-Seleg




Apo-Seleg may be available in the countries listed below.


Ingredient matches for Apo-Seleg



Selegiline

Selegiline hydrochloride (a derivative of Selegiline) is reported as an ingredient of Apo-Seleg in the following countries:


  • Czech Republic

International Drug Name Search

Saturday, December 18, 2010

Solage


Solage is a brand name of mequinol/tretinoin topical, approved by the FDA in the following formulation(s):


SOLAGE (mequinol; tretinoin - solution; topical)



  • Manufacturer: AQUA PHARMS

    Approval date: December 10, 1999

    Strength(s): 2%;0.01% [RLD]

Has a generic version of Solage been approved?


No. There is currently no therapeutically equivalent version of Solage available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Solage. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Synergistic skin depigmentation composition
    Patent 5,194,247
    Issued: March 16, 1993
    Inventor(s): Nair; Xina & Tramposch; Kenneth M.
    There is disclosed a synergistic composition for skin depigmentation with reduced irritation which does not contain a corticosteroid comprising 4-hydroxyanisole and a retinoid, such as all-trans retinoic acid, 11-cis,13-cis-12-hydroxymethyl retinoic acid .delta.-lactone or (N-acetyl-4-aminophenyl) retinoate, in a pharmaceutically acceptable topical vehicle.
    Patent expiration dates:

    • December 10, 2013
      ✓ 
      Patent use: TREATMENT OF HYPERPIGMENTARY DISORDERS
      ✓ 
      Drug product




  • Storage stable tretinoin and 4-hydroxyanisole containing topical composition
    Patent 6,353,029
    Issued: March 5, 2002
    Inventor(s): Prakash V.; Parab
    Assignee(s): Bristol-Myers Squibb Company
    A long-term storage stable tretinoin and 4-hydroxyanisole composition contains low molecular weight polyethylene glycol, antioxidant, a chelating agent, lower alkanol and water. The chelating agent provides at least two of the functions of oxygen scavaging, free radical chain terminating and reducing. The composition has a pH of 2.5 to 5 and a water content of at least 12%.
    Patent expiration dates:

    • August 24, 2020



See also...

  • Solage Consumer Information (Wolters Kluwer)
  • Solage Consumer Information (Cerner Multum)
  • Solage Topical Advanced Consumer Information (Micromedex)
  • Mequinol/Tretinoin Consumer Information (Wolters Kluwer)
  • Mequinol and tretinoin topical Consumer Information (Cerner Multum)
  • Mequinol and tretinoin Topical Advanced Consumer Information (Micromedex)

Ekaril




Ekaril may be available in the countries listed below.


Ingredient matches for Ekaril



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Ekaril in the following countries:


  • Mexico

International Drug Name Search

Thursday, December 16, 2010

Ephedrine




In some countries, this medicine may only be approved for veterinary use.


In the US, Ephedrine (ephedrine systemic) is a member of the following drug classes: decongestants, vasopressors and is used to treat Adams-Stokes Syndrome, Asthma - acute, COPD - Acute, Hypotension and Myasthenia Gravis.

US matches:

  • Ephedrine

  • Ephedrine Capsules

  • Ephedrine/Guaifenesin

  • Ephedrine/Guaifenesin Syrup

  • Ephedrine Hydrochloride

  • Ephedrine Sulfate

  • Ephedrine Sulphate Injection

UK matches:

  • Ephedrine Hydrochloride 15, 30 & 60mg Tablets (Wockhardt UK Ltd) (SPC)

Scheme

Ph. Int.

ATC (Anatomical Therapeutic Chemical Classification)

R01AA03,R01AB05,R03CA02,S01FB02

CAS registry number (Chemical Abstracts Service)

0000299-42-3

Chemical Formula

C10-H15-N-O

Molecular Weight

165

Therapeutic Categories

Bronchodilator

Sympathomimetic agent

Chemical Names

(-)-Ephedrine (Ph. Int.)

(1R,2S)-2-methylamino-1-phenylpropan-1-ol (Ph. Eur.)

(αR)-α-[(1S)-1-(Methylamino)ethyl]benzenemethanol

[R-(R*,S*)]-α-[1-(methylamino)ethyl]benzenemethanol (Ph. Int.)

Benzenemethanol, α-[1-(methylamino)ethyl]-, [R-(R*,S*)]- (USP)

L-erythro-α-[1-(Methylamino)ethyl]benzyl alcohol

L-erythro-2-(methylamino)-1-phenylpropan-1-ol

Foreign Names

  • Ephedrinum anhydricum (Latin)
  • Ephedrin, wasserfrei (German)
  • Ephédrine anhydre (French)
  • Efedrina (Spanish)

Generic Names

  • Ephedrine (OS: BAN)
  • Éphédrine (OS: DCF)
  • 1-Sedrin (IS)
  • NSC 170951 (IS)
  • NSC 8971 (IS)
  • UNII-GN83C131XS (IS)
  • Ephedrin, Wasserfreies (PH: Ph. Eur. 6)
  • Ephedrine (PH: USP 32, Ph. Int. 4)
  • Ephédrine, anhydre (PH: Ph. Eur. 6)
  • Ephedrine, Anhydrous (PH: BP 2010, Ph. Eur. 6)
  • Ephedrinum (PH: Ph. Int. 4)
  • Ephedrinum anhydricum (PH: Ph. Eur. 6)
  • Ephedrine Hydrochloride (OS: JAN, BAN)
  • UNII-NLJ6390P1Z (IS)
  • Ephédrine (chlorhydrate d') (PH: Ph. Eur. 6)
  • Ephedrine Hydrochloride (PH: BP 2010, Ph. Eur. 6, Ph. Int. 4, USP 32, JP XV)
  • Ephedrinhydrochlorid (PH: Ph. Eur. 6)
  • Ephedrini hydrochloridum (PH: Ph. Int. 4, Ph. Eur. 6)
  • Ephedrine Sulphate (OS: BANM)
  • Ephedrine Sulfate (PH: USP 32, Ph. Int. 4)
  • Ephedrini sulfas (PH: Ph. Int. 4)

Brand Names

  • Asthmolysin (Ephedrine and Proxyphylline)
    Maruho, Japan


  • Endrine
    Nycomed, Belgium


  • Ephedrine Aguettant
    Aguettant, Tunisia


  • Hemoal (Ephedrine and Benzocaine)
    Combe, Spain


  • Nasocalma
    Salusif, Portugal


  • Novipec
    Montavit, Austria


  • Sekicode (Ephedrine and Dihydrocodeine)
    Dainippon Sumitomo, Japan


  • Asmadex (Ephedrine and Theophylline)
    Dexa Medica, Indonesia


  • Asmasolon (Ephedrine and Theophylline)
    Probus, Indonesia


  • Asthma Soho (Ephedrine and Theophylline)
    Soho, Indonesia


  • CAM
    Cambridge Healthcare, United Kingdom


  • Caniphedrin (veterinary use)
    Selecta, Germany; Streuli Vet, Switzerland


  • Cilinafosal Neomicina (Ephedrine and Neomycin)
    Medical, Spain


  • Cilinafosal (Ephedrine and Sulfanilamide)
    Medical, Spain


  • Deltarhinol (Ephedrine and Naphazoline)
    Gruppolepetit, Oman


  • Deltarinolo (Ephedrine and Naphazoline)
    Sanofi-Aventis, Italy


  • Efedrin Arsan
    Bilim, Turkey


  • Efedrin Gürsoy
    Gürsoy, Turkey


  • Efedrin Mylan
    Mylan, Sweden


  • Efedrin SAD
    SAD, Denmark


  • Efedrin
    Nycomed, Norway; Osel, Turkey


  • Efedrina Cloridrato Afom
    AFOM, Italy


  • Efedrina Cloridrato Galenica
    Galenica, Italy


  • Efedrina Cloridrato Monico
    Monico, Italy


  • Efedrina Cloridrato Salf
    Salf, Italy


  • Efedrina Level
    Ern, Spain


  • Efedrinã
    Arena, Romania; Sicomed, Romania


  • Efedrine HCl PCH
    Pharmachemie, Netherlands


  • Efedrosan
    Pasteur, Chile


  • Efrinol
    Prolab, Poland


  • Endrine
    Nycomed, Luxembourg


  • Enurace (veterinary use)
    ACE Veterinary, Netherlands


  • Ephedrin Amino
    Amino, Switzerland


  • Ephedrin Biotika
    Biotika, Czech Republic; Biotika, Lithuania; Biotika, Slovakia


  • Ephedrin HCl
    Ethica Industri Farmasi, Indonesia


  • Ephedrin Sintetica
    Sintetica, Switzerland


  • Ephedrin Streuli
    Streuli Pharma, Switzerland


  • Ephedrin
    Dainippon Sumitomo, Japan


  • Ephedrine Aguettant
    Aguettant, Malta


  • Ephédrine Aguettant
    Aguettant, France


  • Ephedrine Beacons
    Beacons, Singapore


  • Ephedrine HCl Berlico
    Berlico Mulia Farma, Indonesia


  • Ephedrine HCL
    IFET, Greece; Rekah, Israel


  • Ephedrine Hydrochloride
    Antigen Pharmaceuticals, Ethiopia; MaCarthys, Malta; PSM, New Zealand; Wockhardt, United Kingdom


  • Ephédrine Renaudin
    Renaudin, France


  • Ephedrine Sopharma
    Sopharma, Bulgaria


  • Ephedrine
    Chinoin Pharmaceutical and Chemical Works, Ethiopia; Jayson, Bangladesh; The Central, Taiwan


  • Ephedrinum hydrochloridum
    Polfa Warszawa, Poland


  • Ephedronguent
    Sterop, Belgium


  • Epherit
    ExtractumPharma, Hungary


  • Fedrin
    Jayson, Bangladesh


  • Fienamina (Ephedrine and Chlorphenamine)
    Recordati, Italy


  • Genasma (Ephedrine and Aminophylline)
    Alliance, South Africa


  • Haymine (Ephedrine and Chlorphenamine)
    Pharmax, Bahrain; Pharmax, Oman


  • Ivyfrin
    Ivee Aqua, Ethiopia


  • Lepheton (Ephedrine and Ethylmorphine)
    Meda, Sweden


  • Mollipect (Ephedrine and Bromhexine)
    BioPhausia, Sweden


  • Remadrin
    Reman Drug, Bangladesh


  • Reukap
    Bosnalijek, Bosnia & Herzegowina


  • Rhinolex (Ephedrine andSulfathiazole)
    Sopharma, Bulgaria


  • Rubital-Compositum
    Gemi, Poland


  • Specifique Éphédrix (Ephedrine and Diprophylline (veterinary use))
    Laboratoire TVM, France


  • Syrop Prawoslazowy zlozony
    Gemi, Poland


  • Theochodil (Ephedrine and Theophylline)
    Global Multi Pharmalab, Indonesia


  • DBL Ephedrine
    Hospira, Australia


  • Efedrin
    Cristália, Brazil


  • Efedrina Sulfato
    Biosano, Chile; Sanderson, Chile


  • Efedrina
    Biol, Argentina


  • Ephedrine Sulfate
    Abbott, United States; Bedford, United States; Hospira, Canada; Hospira, New Zealand; Mayne, Hong Kong


  • Muchan
    Fada, Argentina


  • Sulfato de Efedrina
    Roemmers, Venezuela

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Ph. Eur.European Pharmacopoeia
Ph. Int.Pharmacopoea Internationalis
SPC Summary of Product Characteristics (UK)
USPPharmacopoeia of the United States

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, December 11, 2010

DuoNeb


DuoNeb is a brand name of albuterol/ipratropium, approved by the FDA in the following formulation(s):


DUONEB (albuterol sulfate; ipratropium bromide - solution; inhalation)



  • Manufacturer: DEY

    Approval date: March 21, 2001

    Strength(s): EQ 0.083% BASE;0.017% [RLD][AN]

Has a generic version of DuoNeb been approved?


A generic version of DuoNeb has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to DuoNeb and have been approved by the FDA:


ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE (albuterol sulfate; ipratropium bromide solution; inhalation)



  • Manufacturer: APOTEX CORP

    Approval date: December 31, 2007

    Strength(s): EQ 0.083% BASE;0.017% [AN]


  • Manufacturer: NEPHRON

    Approval date: December 31, 2007

    Strength(s): EQ 0.083% BASE;0.017% [AN]


  • Manufacturer: SANDOZ

    Approval date: December 21, 2006

    Strength(s): EQ 0.083% BASE;0.017% [AN]


  • Manufacturer: TEVA PARENTERAL

    Approval date: December 31, 2007

    Strength(s): EQ 0.083% BASE;0.017% [AN]


  • Manufacturer: WATSON LABS

    Approval date: December 31, 2007

    Strength(s): EQ 0.083% BASE;0.017% [AN], EQ 0.083% BASE;0.017% [AN]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of DuoNeb. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
    Patent 6,632,842
    Issued: October 14, 2003
    Inventor(s): Imtiaz; Chaudry & Partha; Banerjee
    Assignee(s): Dey, L.P.
    The present invention relates to a dual bronchodilator inhalation solution, system, kit and method for relieving bronchospasm in patients suffering from chronic obstructive pulmonary disease (COPD). In one alternative embodiment, the solution of the present invention is a prepackaged, sterile, premixed, premeasured single unit dose of albuterol and ipratropium bromide for patients suffering from COPD. The present solution may be free of antimicrobial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 2.50 mg albuterol and about 0.50 mg ipratropium bromide.
    Patent expiration dates:

    • December 28, 2021
      ✓ 
      Patent use: TREATMENT OF BRONCHOSPASM ASSOCIATED WITH COPD IN PATIENTS REQUIRING MORE THAN ONE BRONCHO DILATOR



See also...

  • DuoNeb Consumer Information (Drugs.com)
  • DuoNeb Solution Consumer Information (Wolters Kluwer)
  • DuoNeb inhalation Consumer Information (Cerner Multum)
  • Duoneb Advanced Consumer Information (Micromedex)
  • Albuterol/Ipratropium Aerosol Consumer Information (Wolters Kluwer)
  • Albuterol/Ipratropium Solution Consumer Information (Wolters Kluwer)
  • Albuterol and ipratropium inhalation Consumer Information (Cerner Multum)
  • Ratio-Ipra Sal Udv Advanced Consumer Information (Micromedex)
  • Ipratropium and albuterol Inhalation, oral/nebulization Advanced Consumer Information (Micromedex)

Thursday, December 9, 2010

Patyuna




Patyuna may be available in the countries listed below.


Ingredient matches for Patyuna



Ticlopidine

Ticlopidine hydrochloride (a derivative of Ticlopidine) is reported as an ingredient of Patyuna in the following countries:


  • Japan

International Drug Name Search

Wednesday, December 8, 2010

Admiral




Admiral may be available in the countries listed below.


Ingredient matches for Admiral



Tenoxicam

Tenoxicam is reported as an ingredient of Admiral in the following countries:


  • Greece

International Drug Name Search

Fentanilo Acostgen




Fentanilo Acostgen may be available in the countries listed below.


Ingredient matches for Fentanilo Acostgen



Fentanyl

Fentanyl is reported as an ingredient of Fentanilo Acostgen in the following countries:


  • Spain

International Drug Name Search

Friday, December 3, 2010

Paracetamol / Codeine A




Paracetamol / Codeine A may be available in the countries listed below.


Ingredient matches for Paracetamol / Codeine A



Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Paracetamol / Codeine A in the following countries:


  • Netherlands

Paracetamol

Paracetamol is reported as an ingredient of Paracetamol / Codeine A in the following countries:


  • Netherlands

International Drug Name Search

Wednesday, December 1, 2010

Divalproex Sprinkle Capsules



Pronunciation: dye-VAL-proe-ex
Generic Name: Divalproex
Brand Name: Depakote

Life-threatening liver failure has occurred in patients taking Divalproex Sprinkle Capsules. Children younger than 2 years old are at increased risk of developing life-threatening liver damage, especially those on more than 1 medicine to treat seizures and those with metabolic disorders, severe seizure disorders accompanied by retardation, or organic brain disease. Contact your doctor immediately if you or your child experiences a general feeling of discomfort, sluggishness, weakness, severe drowsiness, swelling of the face, loss of appetite, vomiting, or loss of seizure control. Liver function tests may be performed before and during therapy with Divalproex Sprinkle Capsules. Be sure to keep all doctor and lab appointments.


Divalproex Sprinkle Capsules can cause severe birth defects if it is used during pregnancy. Contact your doctor if you become pregnant or think you may be pregnant while taking Divalproex Sprinkle Capsules. Divalproex Sprinkle Capsules comes with an additional patient leaflet, "Important Information for Women Who Could Become Pregnant." Read it carefully.


Cases of life-threatening inflammation of the pancreas have occurred with the use of Divalproex Sprinkle Capsules. Report any stomach pain, nausea, vomiting, or loss of appetite to your doctor at once.





Divalproex Sprinkle Capsules are used for:

Controlling certain types of seizures in the treatment of epilepsy. It may also be used for other conditions as determined by your doctor.


Divalproex Sprinkle Capsules are an anticonvulsant. It works by reducing or preventing the number of seizures by controlling the abnormal activity of nerve impulses in the brain and central nervous system.


Do NOT use Divalproex Sprinkle Capsules if:


  • you are allergic to any ingredient in Divalproex Sprinkle Capsules

  • you have liver problems or a urea cycle disorder

Contact your doctor or health care provider right away if any of these apply to you.



Video: Treatment for Depression







Treatments for depression are getting better everyday and there are things you can start doing right away.






Before using Divalproex Sprinkle Capsules:


Some medical conditions may interact with Divalproex Sprinkle Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, are breast-feeding, or are of childbearing age

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of alcohol abuse, liver problems, metabolic disease, blood disease, HIV infection, cytomegalovirus (CMV) infection, high blood levels of ammonia or glutamine, low body temperature, low levels of albumin, brain problems (eg, organic brain disease), mental retardation, inflammation of the pancreas, kidney problems, or low levels of white blood cells, or if you are scheduled for surgery

  • if you have a history of ornithine transcarbamylase deficiency or unexplained coma

  • if you have a family history of urea cycle disorders or unexplained infant deaths

  • if you have a history of mental or mood problems (eg, depression), or suicidal thoughts or actions

  • if you take any other medicine for seizures

Some MEDICINES MAY INTERACT with Divalproex Sprinkle Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Benzodiazepines (eg, diazepam), carbamazepine, erythromycin, felbamate, fluoxetine, guanfacine, isoniazid, ketoconazole, risperidone, or salicylates (eg, aspirin) because the risk of serious side effects of Divalproex Sprinkle Capsules, including blurred vision or other vision problems, clumsiness or unsteadiness, drowsiness, nausea, or vomiting, may be increased

  • Clonazepam because the risk of seizures may be increased

  • Topiramate because the risk of high ammonium levels, brain problems, or an unusual drop in body temperature may be increased

  • Acyclovir, cancer medicines, carbapenem antibiotics (eg, ertapenem, imipenem, meropenem), cholestyramine, hydantoins (eg, phenytoin), mefloquine, nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen), oral contraceptives (eg, birth control pills), or rifampin because they may decrease Divalproex Sprinkle Capsules's effectiveness

  • Anticoagulants (eg, warfarin), barbiturates (eg, phenobarbital), ethosuximide, lamotrigine, methylphenidate, primidone, tolbutamide, tricyclic antidepressants (eg, amitriptyline), or zidovudine because the risk of their side effects may be increased by Divalproex Sprinkle Capsules

This may not be a complete list of all interactions that may occur. Ask your health care provider if Divalproex Sprinkle Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Divalproex Sprinkle Capsules:


Use Divalproex Sprinkle Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • An extra patient leaflet is available with Divalproex Sprinkle Capsules. Talk to your pharmacist if you have questions about this information.

  • Take Divalproex Sprinkle Capsules by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.

  • Swallow Divalproex Sprinkle Capsules whole. Do not break, crush, or chew before swallowing. If you cannot swallow the capsule whole, you may open it and sprinkle the contents over a spoonful of soft food (eg, applesauce, pudding). Mix the medicine with the food and swallow the mixture right away, followed by a glass of water. Do not crush or chew the medicine before swallowing. Do not store the mixture for future use.

  • Do not stop taking Divalproex Sprinkle Capsules suddenly. Suddenly stopping Divalproex Sprinkle Capsules may cause severe seizures to occur. If you need to stop Divalproex Sprinkle Capsules, your doctor will gradually lower your dose.

  • Taking Divalproex Sprinkle Capsules at the same time each day will help you to remember to take it.

  • Continue to take Divalproex Sprinkle Capsules even if you feel well. Do not miss any doses. Divalproex Sprinkle Capsules works best when there is a constant level of it in your body.

  • If you miss a dose of Divalproex Sprinkle Capsules, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Divalproex Sprinkle Capsules.



Important safety information:


  • Divalproex Sprinkle Capsules may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Divalproex Sprinkle Capsules with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Divalproex Sprinkle Capsules; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Patients who take Divalproex Sprinkle Capsules may be at increased risk for suicidal thoughts or actions. The risk may be greater in patients who have had suicidal thoughts or actions in the past. Patients who have bipolar (manic-depressive) illness may also have an increased risk for suicidal thoughts or actions. Watch patients who take Divalproex Sprinkle Capsules closely. Contact the doctor at once if new, worsened, or sudden symptoms, such as depressed mood; anxious, restless, irritable behavior; panic attacks; or any unusual change in mood or behavior occur. Contact the doctor right away if any signs of suicidal thoughts or actions occur.

  • Divalproex Sprinkle Capsules may reduce the number of clot-forming cells (platelets) in your blood. Avoid activities that may cause bruising or injury. Tell your doctor if you have unusual bruising or bleeding. Tell your doctor if you have dark, tarry, or bloody stools.

  • Tell your doctor or dentist that you take Divalproex Sprinkle Capsules before you receive any medical or dental care, emergency care, or surgery.

  • You may notice undissolved parts of Divalproex Sprinkle Capsules in your stool. This is normal and not a cause for concern.

  • Inflammation of the pancreas is a potentially life-threatening illness associated with Divalproex Sprinkle Capsules. Symptoms include stomach pain, vomiting, or loss of appetite. Contact your doctor at once if any of these symptoms occur.

  • Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.

  • Diabetes patients - Divalproex Sprinkle Capsules may cause the results of some tests for urine ketones to be wrong. Ask your doctor before you change your diet or the dose of your diabetes medicine.

  • Divalproex Sprinkle Capsules may increase the ammonia levels in your blood. Contact your doctor right away if you experience unexplained sluggishness and vomiting or mental changes.

  • Divalproex Sprinkle Capsules may cause an unusual drop in body temperature (hypothermia). Symptoms may include confusion, lack of energy, loss of coordination, shivering, slow heartbeat, slow or shallow breathing, slurred speech, or unusual drowsiness. Contact your doctor right away if you have any of these symptoms.

  • Divalproex Sprinkle Capsules may interfere with certain lab tests, including thyroid function. Be sure your doctor and lab personnel know you are taking Divalproex Sprinkle Capsules.

  • Lab tests, including complete blood cell counts, blood ammonia levels, and liver function, may be performed while you use Divalproex Sprinkle Capsules. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Use Divalproex Sprinkle Capsules with caution in the ELDERLY; they may be more sensitive to its effects, especially drowsiness.

  • Divalproex Sprinkle Capsules should be used with extreme caution in CHILDREN younger than 10 years old; safety and effectiveness in these children have not been confirmed. CHILDREN younger than 2 years old may be at increased risk of serious liver problems.

  • PREGNANCY and BREAST-FEEDING: Divalproex Sprinkle Capsules has been shown to cause harm to the fetus. Use an effective form of birth control while you take Divalproex Sprinkle Capsules. If you think you may be pregnant or if you wish to become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Divalproex Sprinkle Capsules while you are pregnant. Divalproex Sprinkle Capsules are found in breast milk. Do not breast-feed while you are taking Divalproex Sprinkle Capsules.


Possible side effects of Divalproex Sprinkle Capsules:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Change in appetite; constipation; diarrhea; dizziness; drowsiness; hair loss; headache; indigestion; nausea; stomach cramps or pain; trouble sleeping; vomiting; weakness; weight changes.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); abnormal thinking; change in menstrual period; changes in behavior; chest pain; confusion; dark, tarry, or bloody stools; dark urine; difficulty speaking; difficulty urinating or other urination problems; extreme tiredness; fast or irregular heartbeat; fever; general body discomfort; hallucinations; hearing loss; involuntary movements of the arms and legs; involuntary movements or chewing movements of the face, jaw, mouth, or tongue; joint pain; lack of energy; loss of appetite; loss of coordination; loss of seizure control; memory loss; new or worsening mental or mood changes (eg, aggressiveness, agitation, anxiety, depression, exaggerated feeling of well-being, hostility, impulsiveness, inability to sit still, irritability, panic attacks, restlessness); nosebleed; pounding in the chest; red, swollen, blistered, or peeling skin; severe or persistent nausea, vomiting, or stomach pain; shortness of breath; suicidal thoughts or actions; swelling of the arms or legs; symptoms of infections (eg, fever, chills, sore throat); tremor; unusual bleeding or bruising; unusual weakness; vision changes or blurred vision; yellowing of the skin or eyes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Divalproex side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include deep sleep; drowsiness; irregular heartbeat; loss of consciousness.


Proper storage of Divalproex Sprinkle Capsules:

Store Divalproex Sprinkle Capsules between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Divalproex Sprinkle Capsules out of the reach of children and away from pets.


General information:


  • If you have any questions about Divalproex Sprinkle Capsules, please talk with your doctor, pharmacist, or other health care provider.

  • Divalproex Sprinkle Capsules are to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Divalproex Sprinkle Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Divalproex resources


  • Divalproex Side Effects (in more detail)
  • Divalproex Use in Pregnancy & Breastfeeding
  • Drug Images
  • Divalproex Drug Interactions
  • Divalproex Support Group
  • 129 Reviews for Divalproex - Add your own review/rating


Compare Divalproex with other medications


  • Bipolar Disorder
  • Epilepsy
  • Hyperekplexia
  • Mania
  • Migraine Prevention

Thursday, November 25, 2010

Verapamil A




Verapamil A may be available in the countries listed below.


Ingredient matches for Verapamil A



Verapamil

Verapamil hydrochloride (a derivative of Verapamil) is reported as an ingredient of Verapamil A in the following countries:


  • Netherlands

International Drug Name Search

Sunday, November 21, 2010

Rilmenidine




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C02AC06

CAS registry number (Chemical Abstracts Service)

0054187-04-1

Chemical Formula

C10-H16-N2-O

Molecular Weight

180

Therapeutic Categories

Antihypertensive agent

α₂-Sympathomimetic agent

Chemical Name

2-Oxazolamine, N-(dicyclopropylmethyl)-4,5-dihydro-

Foreign Names

  • Rilmenidinum (Latin)
  • Rilmenidin (German)
  • Rilménidine (French)
  • Rilmenidina (Spanish)

Generic Names

  • Rilménidine (OS: DCF)
  • S 3341 (IS: Servier)
  • Rilmenidin Dihydrogen Phosphate (PH: BP 2010, Ph. Eur. 6)
  • Rilmenidini dihydrogenophosphas (PH: Ph. Eur. 6)

Brand Names

  • Albarel
    Egis, Poland


  • Hyperium
    Servier, Netherlands Antilles; Servier, Aruba; Servier, Barbados; Servier, Bermuda; Servier, Bahamas; Servier, Grenada; Servier, Guyana; Servier, Jamaica; Servier, Cayman Islands; Servier, Saint Lucia; Servier, Oman; Servier, Trinidad & Tobago; Servier, Saint Vincent & The Grenadines; Servier, Vietnam


  • Iperdix
    Servier, Hong Kong


  • Albarel
    Egis, Russian Federation


  • Hyperdix
    Servier, Philippines; Servier, Thailand


  • Hyperium
    Biopharma, France; Servier, Argentina; Servier, Brazil; Servier, Luxembourg; Servier, Malta; Servier, Portugal; Servier, Turkey; Servier, Venezuela


  • Iterium
    Servier, Austria


  • Rilménidine Arrow
    Arrow, France


  • Rilménidine Biogaran
    Biogaran, France


  • Rilménidine EG
    EG Labo, France


  • Rilménidine Merck
    Mylan, France


  • Rilménidine Qualimed
    Qualimed, France


  • Rilménidine Ranbaxy
    RPG, France


  • Rilménidine Ratiopharm
    Ratiopharm, France


  • Rilménidine Sandoz
    Sandoz, France


  • Rilménidine Winthrop
    Sanofi-Aventis, France


  • Rilménidine Zydus
    Zydus, France


  • Tenaxum
    Egis, Hungary; Servier, Bulgaria; Servier, Czech Republic; Servier, Lithuania; Servier, Latvia; Servier, Poland; Servier, Romania; Servier, Slovakia

International Drug Name Search

Glossary

DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, November 20, 2010

Uniciclina




Uniciclina may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Uniciclina



Oxytetracycline

Oxytetracycline is reported as an ingredient of Uniciclina in the following countries:


  • Italy

International Drug Name Search

Friday, November 19, 2010

Amitriptylin beta




Amitriptylin beta may be available in the countries listed below.


Ingredient matches for Amitriptylin beta



Amitriptyline

Amitriptyline hydrochloride (a derivative of Amitriptyline) is reported as an ingredient of Amitriptylin beta in the following countries:


  • Germany

International Drug Name Search

Biocani Tique




Biocani Tique may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Biocani Tique



Amitraz

Amitraz is reported as an ingredient of Biocani Tique in the following countries:


  • France

International Drug Name Search

Thursday, November 18, 2010

Anadiol




Anadiol may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Anadiol



Methandriol

Methandriol 3ß,17ß-dipropionate (a derivative of Methandriol) is reported as an ingredient of Anadiol in the following countries:


  • Australia

International Drug Name Search

Ceonomal




Ceonomal may be available in the countries listed below.


Ingredient matches for Ceonomal



Arotinolol

Arotinolol hydrochloride (a derivative of Arotinolol) is reported as an ingredient of Ceonomal in the following countries:


  • Japan

International Drug Name Search

Solugel




Solugel may be available in the countries listed below.


Ingredient matches for Solugel



Benzoyl Peroxide

Benzoyl Peroxide is reported as an ingredient of Solugel in the following countries:


  • Argentina

  • Canada

  • Chile

  • Dominican Republic

  • El Salvador

  • Guatemala

  • Honduras

  • Mexico

  • Nicaragua

  • Panama

  • Peru

  • Tunisia

  • Venezuela

International Drug Name Search

Monday, November 15, 2010

Flavix




Flavix may be available in the countries listed below.


Ingredient matches for Flavix



Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Flavix in the following countries:


  • India

International Drug Name Search

Saturday, November 13, 2010

Pulmicort Turbohaler




UK matches:

  • Pulmicort Turbohaler
  • Pulmicort Turbohaler 100 (SPC)
  • Pulmicort Turbohaler 200 (SPC)
  • Pulmicort Turbohaler 400 (SPC)

Ingredient matches for Pulmicort Turbohaler



Budesonide

Budesonide is reported as an ingredient of Pulmicort Turbohaler in the following countries:


  • Austria

  • Bahrain

  • Croatia (Hrvatska)

  • Cyprus

  • Egypt

  • Germany

  • Ghana

  • Iraq

  • Ireland

  • Jordan

  • Kenya

  • Kuwait

  • Lebanon

  • Libya

  • Luxembourg

  • Malawi

  • Malta

  • Mozambique

  • Nigeria

  • Oman

  • Poland

  • Portugal

  • Qatar

  • Saudi Arabia

  • Sudan

  • Syria

  • Tanzania

  • Uganda

  • United Arab Emirates

  • United Kingdom

  • United States

  • Yemen

  • Zambia

  • Zimbabwe

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, November 8, 2010

Plusplatin




Plusplatin may be available in the countries listed below.


Ingredient matches for Plusplatin



Oxaliplatin

Oxaliplatin is reported as an ingredient of Plusplatin in the following countries:


  • Argentina

International Drug Name Search

Saturday, November 6, 2010

Propranolol Helvepharm




Propranolol Helvepharm may be available in the countries listed below.


Ingredient matches for Propranolol Helvepharm



Propranolol

Propranolol hydrochloride (a derivative of Propranolol) is reported as an ingredient of Propranolol Helvepharm in the following countries:


  • Switzerland

International Drug Name Search

Sunday, October 24, 2010

Duphacycline Spray




Duphacycline Spray may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Duphacycline Spray



Oxytetracycline

Oxytetracycline hydrochloride (a derivative of Oxytetracycline) is reported as an ingredient of Duphacycline Spray in the following countries:


  • Netherlands

International Drug Name Search

Saturday, October 23, 2010

Plovacal




Plovacal may be available in the countries listed below.


Ingredient matches for Plovacal



Paracetamol

Paracetamol is reported as an ingredient of Plovacal in the following countries:


  • Argentina

International Drug Name Search

Friday, October 15, 2010

Docparacod




Docparacod may be available in the countries listed below.


Ingredient matches for Docparacod



Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Docparacod in the following countries:


  • Belgium

Paracetamol

Paracetamol is reported as an ingredient of Docparacod in the following countries:


  • Belgium

International Drug Name Search

Klarpharma




Klarpharma may be available in the countries listed below.


Ingredient matches for Klarpharma



Clarithromycin

Clarithromycin is reported as an ingredient of Klarpharma in the following countries:


  • Mexico

International Drug Name Search

Wednesday, October 6, 2010

Sulfoprima




Sulfoprima may be available in the countries listed below.


Ingredient matches for Sulfoprima



Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Sulfoprima in the following countries:


  • Ethiopia

Trimethoprim

Trimethoprim is reported as an ingredient of Sulfoprima in the following countries:


  • Ethiopia

International Drug Name Search

Tuesday, October 5, 2010

Prelon




Prelon may be available in the countries listed below.


Ingredient matches for Prelon



Prednisolone

Prednisolone is reported as an ingredient of Prelon in the following countries:


  • Japan

International Drug Name Search

Saturday, October 2, 2010

Retisert




In the US, Retisert (fluocinolone ophthalmic) is a member of the drug class ophthalmic steroids and is used to treat Uveitis.

US matches:

  • Retisert

  • Retisert Implant

  • Retisert eent

Ingredient matches for Retisert



Fluocinolone

Fluocinolone Acetonide is reported as an ingredient of Retisert in the following countries:


  • United States

International Drug Name Search

Thursday, September 23, 2010

Opticrom


Opticrom is a brand name of cromolyn ophthalmic, approved by the FDA in the following formulation(s):


OPTICROM (cromolyn sodium - solution/drops; ophthalmic)



  • Manufacturer: ALLERGAN

    Approval date: October 3, 1984

    Strength(s): 4% [RLD][AT]

Has a generic version of Opticrom been approved?


Yes. The following products are equivalent to Opticrom:


CROLOM (cromolyn sodium solution/drops; ophthalmic)



  • Manufacturer: BAUSCH AND LOMB

    Approval date: January 30, 1995

    Strength(s): 4% [AT]

cromolyn sodium solution/drops; ophthalmic



  • Manufacturer: AKORN

    Approval date: April 29, 1998

    Strength(s): 4% [AT]


  • Manufacturer: ALCON

    Approval date: June 16, 1999

    Strength(s): 4% [AT]


  • Manufacturer: NOVEX

    Approval date: January 26, 2001

    Strength(s): 4% [AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Opticrom. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Opticrom.

See also...

  • Opticrom ophthalmic Consumer Information (Cerner Multum)
  • Cromolyn Drops Consumer Information (Wolters Kluwer)
  • Cromolyn ophthalmic Consumer Information (Cerner Multum)
  • Cromolyn sodium ophthalmic Consumer Information (Cerner Multum)
  • Cromolyn Ophthalmic Advanced Consumer Information (Micromedex)
  • Cromolyn Sodium eent AHFS DI Monographs (ASHP)

Wednesday, September 22, 2010

Laboterol




Laboterol may be available in the countries listed below.


Ingredient matches for Laboterol



Clotrimazole

Clotrimazole is reported as an ingredient of Laboterol in the following countries:


  • Chile

International Drug Name Search

Tuesday, September 14, 2010

Ofloxacin-Darnitsa




Ofloxacin-Darnitsa may be available in the countries listed below.


Ingredient matches for Ofloxacin-Darnitsa



Ofloxacin

Ofloxacin is reported as an ingredient of Ofloxacin-Darnitsa in the following countries:


  • Georgia

International Drug Name Search

Sunday, September 12, 2010

Dextropropoxyphène Paracétamol Zydus




Dextropropoxyphène Paracétamol Zydus may be available in the countries listed below.


Ingredient matches for Dextropropoxyphène Paracétamol Zydus



Dextropropoxyphene

Dextropropoxyphene hydrochloride (a derivative of Dextropropoxyphene) is reported as an ingredient of Dextropropoxyphène Paracétamol Zydus in the following countries:


  • France

Paracetamol

Paracetamol is reported as an ingredient of Dextropropoxyphène Paracétamol Zydus in the following countries:


  • France

International Drug Name Search

Saturday, September 11, 2010

Poenglaucol




Poenglaucol may be available in the countries listed below.


Ingredient matches for Poenglaucol



Carteolol

Carteolol hydrochloride (a derivative of Carteolol) is reported as an ingredient of Poenglaucol in the following countries:


  • Argentina

International Drug Name Search

Laiwoxing




Laiwoxing may be available in the countries listed below.


Ingredient matches for Laiwoxing



Levofloxacin

Levofloxacin is reported as an ingredient of Laiwoxing in the following countries:


  • China

International Drug Name Search

Tuesday, September 7, 2010

Fulmeta




Fulmeta may be available in the countries listed below.


Ingredient matches for Fulmeta



Mometasone

Mometasone 17-(2-furoate) (a derivative of Mometasone) is reported as an ingredient of Fulmeta in the following countries:


  • Japan

International Drug Name Search

Thursday, September 2, 2010

Glucosamart




Glucosamart may be available in the countries listed below.


Ingredient matches for Glucosamart



Chondroitin Polysulfate

Chondroitin Polysulfate is reported as an ingredient of Glucosamart in the following countries:


  • Peru

Glucosamine

Glucosamine hydrochloride (a derivative of Glucosamine) is reported as an ingredient of Glucosamart in the following countries:


  • Peru

International Drug Name Search

Saturday, August 28, 2010

Loflazépate d'éthyle




Loflazépate d'éthyle may be available in the countries listed below.


Ingredient matches for Loflazépate d'éthyle



Ethyl Loflazepate

Loflazépate d'éthyle (DCF) is also known as Ethyl Loflazepate (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, August 25, 2010

Pantoloc




Pantoloc may be available in the countries listed below.


Ingredient matches for Pantoloc



Pantoprazole

Pantoprazole is reported as an ingredient of Pantoloc in the following countries:


  • China

  • India

  • Taiwan

  • Vietnam

Pantoprazole sodium (a derivative of Pantoprazole) is reported as an ingredient of Pantoloc in the following countries:


  • Austria

  • Canada

  • Denmark

  • Georgia

  • Hong Kong

  • Philippines

  • South Africa

  • Sweden

  • Vietnam

International Drug Name Search

Sunday, August 22, 2010

Flumicon




Flumicon may be available in the countries listed below.


Ingredient matches for Flumicon



Fluconazole

Fluconazole is reported as an ingredient of Flumicon in the following countries:


  • Italy

International Drug Name Search

Thursday, August 12, 2010

Nizatidine Novexal




Nizatidine Novexal may be available in the countries listed below.


Ingredient matches for Nizatidine Novexal



Nizatidine

Nizatidine is reported as an ingredient of Nizatidine Novexal in the following countries:


  • Greece

International Drug Name Search

Wednesday, August 11, 2010

Idrocortisone Acetato




Idrocortisone Acetato may be available in the countries listed below.


Ingredient matches for Idrocortisone Acetato



Hydrocortisone

Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Idrocortisone Acetato in the following countries:


  • Italy

International Drug Name Search

Wednesday, August 4, 2010

AD3




AD3 may be available in the countries listed below.


Ingredient matches for AD3



Colecalciferol

Colecalciferol is reported as an ingredient of AD3 in the following countries:


  • Slovenia

Retinol

Retinol is reported as an ingredient of AD3 in the following countries:


  • Slovenia

International Drug Name Search

Saturday, July 31, 2010

Axsain




In the US, Axsain (capsaicin topical) is a member of the drug class miscellaneous topical agents and is used to treat Diabetic Nerve Damage, Osteoarthritis and Persisting Pain - Shingles.

US matches:

  • Axsain Cream

  • Axsain

  • Axsain Topical

UK matches:

  • Axsain
  • Axsain (Cephalon (UK) Limited) (SPC)

Ingredient matches for Axsain



Capsaicin

Capsaicin is reported as an ingredient of Axsain in the following countries:


  • Ireland

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, July 26, 2010

Allopur




Allopur may be available in the countries listed below.


Ingredient matches for Allopur



Allopurinol

Allopurinol is reported as an ingredient of Allopur in the following countries:


  • Norway

  • Switzerland

International Drug Name Search

Saturday, July 24, 2010

Nefopam




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N02BG06

CAS registry number (Chemical Abstracts Service)

0013669-70-0

Chemical Formula

C17-H19-N-O

Molecular Weight

253

Therapeutic Category

Analgesic and antipyretic

Chemical Name

1H-2,5-Benzoxazocine, 3,4,5,6-tetrahydro-5-methyl-1-phenyl-

Foreign Names

  • Nefopamum (Latin)
  • Nefopam (German)
  • Néfopam (French)
  • Nefopam (Spanish)

Generic Names

  • Nefopam (OS: DCIT, BAN)
  • Néfopam (OS: DCF)
  • Nefopam Hydrochloride (OS: BANM, USAN)
  • Fenazoxine (IS)
  • R 738 (IS)

Brand Names

  • Acupan
    Biocodex, Tunisia; 3M, Bahrain; 3M, Israel; 3M, Kenya; 3M, Zimbabwe; Biocodex, France; Douglas, New Zealand; Meda, Belgium; Meda, United Kingdom; Meda, Ireland; Meda, Luxembourg


  • Dosidol
    Domesco, Vietnam


  • Glosic
    Glomed, Vietnam


  • Nefogesic
    Dar-Al-Dawa, United Arab Emirates; Dar-Al-Dawa, Bahrain; Dar-Al-Dawa, Iraq; Dar-Al-Dawa, Lebanon; Dar-Al-Dawa, Libya; Dar-Al-Dawa, Nigeria; Dar-Al-Dawa, Oman; Dar-Al-Dawa, Saudi Arabia; Dar-Al-Dawa, Sudan; Dar-Al-Dawa, Yemen


  • Nefopam
    Jelfa, Poland


  • Nisidol
    Zenith Biochemicals, Vietnam


  • Oxadol
    Pharma Riace, Russian Federation


  • Panagesic
    Medochemie, Taiwan

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, July 20, 2010

Triazolam ABC




Triazolam ABC may be available in the countries listed below.


Ingredient matches for Triazolam ABC



Triazolam

Triazolam is reported as an ingredient of Triazolam ABC in the following countries:


  • Italy

International Drug Name Search

Saturday, July 17, 2010

Servizol




Servizol may be available in the countries listed below.


Ingredient matches for Servizol



Metronidazole

Metronidazole benzoate (a derivative of Metronidazole) is reported as an ingredient of Servizol in the following countries:


  • Ethiopia

International Drug Name Search

Friday, July 16, 2010

Triateckit




Triateckit may be available in the countries listed below.


Ingredient matches for Triateckit



Ramipril

Ramipril is reported as an ingredient of Triateckit in the following countries:


  • France

International Drug Name Search

Thursday, July 15, 2010

Gazella




Gazella may be available in the countries listed below.


Ingredient matches for Gazella



Levocetirizine

Levocetirizine is reported as an ingredient of Gazella in the following countries:


  • Peru

International Drug Name Search

Tuesday, July 13, 2010

Elantan




Elantan may be available in the countries listed below.


UK matches:

  • Elantan 10 (SPC)
  • Elantan 20 (SPC)
  • Elantan 40 (SPC)
  • Elantan LA25 (SPC)
  • Elantan LA50 (SPC)

Ingredient matches for Elantan



Isosorbide Mononitrate

Isosorbide Mononitrate is reported as an ingredient of Elantan in the following countries:


  • China

  • Ecuador

  • Estonia

  • Germany

  • Hong Kong

  • Ireland

  • Latvia

  • Lithuania

  • Luxembourg

  • Malaysia

  • Oman

  • Peru

  • Philippines

  • Singapore

  • South Africa

  • Sri Lanka

  • Thailand

  • United Kingdom

  • Venezuela

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, July 11, 2010

Maverex




Maverex may be available in the countries listed below.


Ingredient matches for Maverex



Vinorelbine

Vinorelbine is reported as an ingredient of Maverex in the following countries:


  • Russian Federation

International Drug Name Search

Thursday, July 1, 2010

Injectio Codeine Phosphatis




Injectio Codeine Phosphatis may be available in the countries listed below.


Ingredient matches for Injectio Codeine Phosphatis



Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Injectio Codeine Phosphatis in the following countries:


  • Taiwan

International Drug Name Search

Glevate




Glevate may be available in the countries listed below.


Ingredient matches for Glevate



Clobetasol

Clobetasol 17α-propionate (a derivative of Clobetasol) is reported as an ingredient of Glevate in the following countries:


  • Philippines

  • Venezuela

International Drug Name Search

Friday, June 25, 2010

bimatoprost ophthalmic


Generic Name: bimatoprost ophthalmic (bih MAT o prost)

Brand Names: Lumigan


What is bimatoprost ophthalmic?

Bimatoprost ophthalmic reduces pressure in the eye by increasing the amount of fluid that drains from the eye.


Bimatoprost ophthalmic is used to treat certain types of glaucoma and other causes of high pressure inside the eye. Bimatoprost is also used to improve fullness, length, and color of the eyelashes in people with a condition called hypotrichosis (HYE-poe-trye-KOE-sis), a lack of eyelash growth.

Bimatoprost ophthalmic may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about bimatoprost ophthalmic?


Do not use this medication while you are wearing contact lenses. This medication may contain a preservative that can be absorbed by soft contact lenses. Wait at least 15 minutes after using bimatoprost before putting your contact lenses in.

Bimatoprost ophthalmic may cause a gradual change in the color of your eyes or eyelids and lashes, as well as increased growth or thickness of your eyelashes. These color changes, usually an increase in brown pigment, occur slowly and you may not notice them for months or years. Color changes may be permanent even after your treatment ends, and may occur only in the eye being treated. This could result in a cosmetic difference in eye or eyelash color from one eye to the other.


Do not allow the dropper to touch any surface, including the eyes or hands. If the dropper becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye.

After using this medication, wait at least 5 minutes before using any other eye drops that your doctor has prescribed.


What should I discuss with my health care provider before using bimatoprost ophthalmic?


Do not use this medication if you are allergic to bimatoprost.

Before using bimatoprost, tell your doctor if you are allergic to any drugs, or if you have swelling or infection of your eye.


Bimatoprost ophthalmic may cause a gradual change in the color of your eyes or eyelids and lashes, as well as increased growth or thickness of your eyelashes. These color changes, usually an increase in brown pigment, occur slowly and you may not notice them for months or years. Color changes may be permanent even after your treatment ends, and may occur only in the eye being treated. This could result in a cosmetic difference in eye or eyelash color from one eye to the other.


FDA pregnancy category C. It is not known whether bimatoprost is harmful to an unborn baby. Before using this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether bimatoprost passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I use bimatoprost ophthalmic?


Do not use this medication while you are wearing contact lenses. This medication may contain a preservative that can be absorbed by soft contact lenses. Wait at least 15 minutes after using bimatoprost before putting your contact lenses in.

Use this medication exactly as it was prescribed for you. Do not use the medication in larger amounts, or use it for longer than recommended by your doctor. Follow the instructions on your prescription label.


Wash your hands before using the eye drops.


To apply the eye drops:



  • Tilt your head back slightly and pull down on the lower eyelid to create a small pocket. Hold the dropper above the eye with the dropper tip down. Look up and away from the dropper. Squeeze out a drop and close your eye. Gently press your finger to the inside corner of the eye (near the nose) for about 1 minute to keep the liquid from draining into your tear duct.




  • If you use more than one drop in the same eye, wait about 5 minutes before putting in the next drop. Also wait at least 5 minutes before using any other eye drops that your doctor has prescribed.




Do not allow the dropper to touch any surface, including the eyes or hands. If the dropper becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye. At any time during your use of bimatoprost ophthalmic, tell your doctor at once if you have an eye injury, if you develop an eye infection, or if you plan to have eye surgery. Do not use the eye drops if the liquid changes colors or has particles in it. Store the drops at room temperature away from heat and moisture. Keep the bottle tightly closed when not in use.

What happens if I miss a dose?


Use the medication as soon as you remember. If it is almost time for the next dose, skip the missed dose and use the medicine at the next regularly scheduled time. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

An overdose of bimatoprost ophthalmic used in the eyes is not expected to produce life-threatening symptoms.


What should I avoid while using bimatoprost ophthalmic?


Avoid using too much of this medication, which can actually make it less effective in lowering the pressure inside the eye.

Avoid using any eyedrop medicine that has not been prescribed by your doctor.


Bimatoprost ophthalmic side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using bimatoprost ophthalmic and call your doctor at once if you have any of these serious side effects:

  • redness, swelling, itching, or pain in or around your eye;




  • oozing or discharge from your eye;




  • increased sensitivity to light;




  • vision changes.



Less serious side effects may include:



  • mild eye discomfort;




  • dizziness;




  • feeling like something is in your eye;




  • dry or watery eyes; or




  • stinging or burning of the eyes after using the drops.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


Bimatoprost ophthalmic Dosing Information


Usual Adult Dose for Intraocular Hypertension:

Instill 1 drop in the affected eye(s) once daily in the evening.

Usual Adult Dose for Glaucoma (Open Angle):

Instill 1 drop in the affected eye(s) once daily in the evening.

Usual Pediatric Dose for Intraocular Hypertension:

16 years and older:

Instill 1 drop in the affected eye(s) once daily in the evening.

Usual Pediatric Dose for Glaucoma (Open Angle):

16 years and older:

Instill 1 drop in the affected eye(s) once daily in the evening.


What other drugs will affect bimatoprost ophthalmic?


There may be other drugs that can affect bimatoprost ophthalmic. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.



More bimatoprost ophthalmic resources


  • Bimatoprost ophthalmic Dosage
  • Bimatoprost ophthalmic Use in Pregnancy & Breastfeeding
  • Bimatoprost ophthalmic Drug Interactions
  • Bimatoprost ophthalmic Support Group
  • 4 Reviews for Bimatoprost - Add your own review/rating


  • Lumigan Prescribing Information (FDA)

  • Lumigan Monograph (AHFS DI)

  • Lumigan Advanced Consumer (Micromedex) - Includes Dosage Information

  • Lumigan Drops MedFacts Consumer Leaflet (Wolters Kluwer)

  • Lumigan Consumer Overview



Compare bimatoprost ophthalmic with other medications


  • Glaucoma, Open Angle
  • Intraocular Hypertension


Where can I get more information?


  • Your pharmacist can provide more information about bimatoprost ophthalmic.


Tuesday, June 22, 2010

Eracillin-K




Eracillin-K may be available in the countries listed below.


Ingredient matches for Eracillin-K



Phenoxymethylpenicillin

Phenoxymethylpenicillin potassium (a derivative of Phenoxymethylpenicillin) is reported as an ingredient of Eracillin-K in the following countries:


  • Bangladesh

International Drug Name Search

Saturday, June 19, 2010

Mydfrin




In the US, Mydfrin (phenylephrine ophthalmic) is a member of the following drug classes: mydriatics, ophthalmic antihistamines and decongestants and is used to treat Eye Dryness/Redness, Eye Redness/Itching and Pupillary Dilation.

US matches:

  • Mydfrin

  • Mydfrin Ophthalmic

Ingredient matches for Mydfrin



Phenylephrine

Phenylephrine hydrochloride (a derivative of Phenylephrine) is reported as an ingredient of Mydfrin in the following countries:


  • Botswana

  • Chile

  • Eritrea

  • Ghana

  • Kenya

  • Malawi

  • Namibia

  • Nigeria

  • Peru

  • Singapore

  • Tanzania

  • Turkey

  • Uganda

  • United States

  • Zambia

  • Zimbabwe

International Drug Name Search

Insulin Humodar C25




Insulin Humodar C25 may be available in the countries listed below.


Ingredient matches for Insulin Humodar C25



Insulin Injection, Biphasic Isophane

Insulin Injection, Biphasic Isophane human (a derivative of Insulin Injection, Biphasic Isophane) is reported as an ingredient of Insulin Humodar C25 in the following countries:


  • Serbia

International Drug Name Search

Thursday, June 17, 2010

Penicillin




In some countries, this medicine may only be approved for veterinary use.


In the US, Penicillin (penicillin systemic) is a member of the drug class natural penicillins and is used to treat Actinomycosis, Anthrax, Anthrax Prophylaxis, Aspiration Pneumonia, Bacterial Infection, Clostridial Infection, Congenital Syphilis, Cutaneous Bacillus anthracis, Deep Neck Infection, Diphtheria, Endocarditis, Fusospirochetosis - Trench Mouth, Joint Infection, Leptospirosis, Lyme Disease - Arthritis, Lyme Disease - Carditis, Lyme Disease - Erythema Chronicum Migrans, Lyme Disease - Neurologic, Meningitis, Meningitis - Meningococcal, Meningitis - Pneumococcal, Neurosyphilis, Otitis Media, Pneumonia, Prevention of Perinatal Group B Streptococcal Disease, Rat-bite Fever, Rheumatic Fever Prophylaxis, Skin Infection, Strep Throat, Syphilis - Early, Syphilis - Latent, Tertiary Syphilis, Tonsillitis/Pharyngitis and Upper Respiratory Tract Infection.

US matches:

  • Penicillin

  • Penicillin G Benzathine Suspension

  • Penicillin G Benzathine/Penicillin G Procaine Suspension

  • Penicillin G Potassium

  • Penicillin G Procaine Injectable Suspension

  • Penicillin G Sodium

  • Penicillin V Potassium

  • Penicillin V Potassium Solution

  • Penicillin-VK

  • Penicillin-VK Solution

  • Penicillin G benzathine

  • Penicillin G potassium injection

  • Penicillin V

  • Penicillin Oral, Injection, Intravenous, Intramuscular

  • Penicillin G Benzathine/Potassium/Sodium

  • Penicillin G Sodium Injection

  • Penicillin G Injection

  • Penicillin G Procaine

  • Penicillin VK

  • Penicillin G

  • Penicillin G Benzathine/Penicillin G Procaine

  • Penicillin V (Phenoxymethyl Penicillin, Penicillin V Potassium)

Ingredient matches for Penicillin



Benzylpenicillin

Benzylpenicillin potassium (a derivative of Benzylpenicillin) is reported as an ingredient of Penicillin in the following countries:


  • Hungary

Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Penicillin in the following countries:


  • United States

Benzylpenicillin sodium (a derivative of Benzylpenicillin) is reported as an ingredient of Penicillin in the following countries:


  • Norway

International Drug Name Search